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Malaria continues to have a high morbidity rate associated among European travelers. Thorough recording
of epidemiological and clinical aspects of imported malaria has been helpful in the detection of new outbreaks
and areas of developing drug resistance. Sentinel surveillance of data collected prospectively since 1999 has
begun within TropNetEurop, a European network focusing on imported infectious diseases. TropNetEurop
appears to cover ∼10% of all patients with malaria seen in Europe. Reports of 1659 immigrants and European
patients with Plasmodium falciparum malaria were analyzed for epidemiological information and data on
clinical features. Regional data were quite diverse, reflecting local patterns of immigration and international
travel. By far, the most infections were imported from West Africa. Europeans had more clinical complications;
consequently, all deaths occurred in this group. Compared with European standards, the mortality rate was
low (0.6% in Europeans). Data from TropNetEurop member sites can contribute to our understanding of the
epidemiological and clinical findings regarding imported falciparum malaria.
Malaria presents a serious health hazard for travelers to
areas of endemicity. In recent decades, the growing pop-
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ularity of international air travel to tropical destinations
has brought a steady increase in the number of imported
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Figure 1. Importation of cases of falciparum malaria to Europe—distribution of reports among European Network on Surveillance of Imported
Infectious Diseases sites.
cases of malaria in countries in which the disease is not endemic
[1–6].
Health practitioners in the Western world face a broad spec-
trum of characteristics when encountering patients with malaria,
from the moderately compromised individual with few nonspe-
cific symptoms (primarily the semi-immune immigrant) to the
critically ill nonimmune traveler. Although malaria is a notifiable
disease in almost all European countries, reliable estimates of the
true number of imported cases are difficult to obtain because
significant underreporting occurs. On average, the number of
reported cases adds up to 11,000 patients per year in European
Union countries, with the numbers of patients with falciparum
malaria estimated at ∼8000 per year [7]. Significant underre-
porting is assumed. Furthermore, details on patients’ travel his-
tory, symptoms, and the clinical course of the disease after treat-
ment may be available for single countries but not for all of
Europe.
Because there is a general lack of surveillance data on imported
cases of infectious diseases in Europe, the European Network on
Imported Infectious Disease Surveillance (TropNetEurop), was
founded in February 1999 as an electronic network of clinical
sites related to imported infectious diseases. The network is
designed to effectively detect, at their point of entry into the
domestic population, emerging infections with potential re-
gional, national, or global impact. Sentinel surveillance re-
porting is performed by participating sites by use of a stan-
dardized and computerized reporting system. Immediate
transmission of anonymous patient and laboratory data to the
central database ensures timely detection of sentinel events. The
comprehensive collection of data on notifiable and nonnoti-
fiable infectious diseases among travelers makes it possible to
identify needs for further surveillance and investigation and
also provides the potential for future case-control studies by
identification of specific risk factors. Primary objectives of
TropNetEurop are (1) to construct and maintain a collaborative
research network of clinical sites in Europe that deal with im-
ported infectious diseases, and (2) to establish and maintain a
clinical network for effective sentinel surveillance of imported
infectious diseases in Europe. Membership is self-selected by
participating centers and is monitored by the steering com-
mittee of the network. Although the organization of the net-
work does not guarantee a representative data collection for
Europe, most referral centers in Europe are represented. From
the beginning, malaria has been one of the major targets within
this network of 36 clinical sites throughout 14 European coun-
tries. This report summarizes results from the first 2 years of
sentinel surveillance for imported malaria.
PATIENTS, MATERIALS, AND METHODS
Member sites of the TropNetEurop network cover ∼51,000 pa-
tients per year. During the period 1999–2000, 1659 patients with
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Figure 2. Type of traveler and geographical region where infection with falciparum malaria occurred [%]
falciparum malaria were reported by 31 sites within the network.
For every patient, the final diagnosis was qualified by the re-
porting center as “probable,” “suspected,” or “confirmed.” A
standardized and anonymous questionnaire was used for data
submission. Reported patients were classified according to 2
categories: (1) patient classification (immigrants, refugees, and
foreign visitors to Europe were considered one group, and stu-
dents, tourists, business travelers, expatriates, military, and mis-
sionaries in the other group), and (2) reason for travel (e.g.,
tourism, business, immigration, research/education, mission-
ary/volunteer/humanitarian aid, or visiting relatives/friends).
Travel and case histories were analyzed for clinical and epi-
demiological features of the infection. Presenting symptoms
were analyzed, taking multiple entries by patients into account.
Individual data points were stored in a computerized database
(Access; Microsoft) and were analyzed by Epi Info (World
Health Organization and Centers for Disease Control and Pre-
vention). Data on patients who were repeatedly admitted for
recrudescent falciparum malaria were analyzed only once to
determine epidemiological background, whereas data on all pa-
tients admitted were considered for clinical analysis.
RESULTS
Of the 1659 patients with falciparum malaria reported during
the evaluated period, mixed infections occurred in 27 (Plas-
modium falciparum and Plasmodium vivax in 11 patients, P.
falciparum and Plasmodium ovale in 10, and P. falciparum and
Plasmodium malariae in 6. For further analysis, patients were
classified into 2 groups: (1) immigrants, per definition includ-
ing semi-immune patients, and (2) European travelers. Im-
migrants accounted for 790 patients (47.6%); 557 (70.5%) were
male and 233 (29.5%) were female. The definition “European
traveler” was fulfilled by 869 patients (52.4%); 563 (64.8%)
were male and 306 (35.2%) were female. The distribution of
reports from different European regions to TropNetEurop is
shown in figure 1.
The average age of reported patients was 30.7 years (median,
36 years; range, 3–67 years) for those in the immigrant group
and 35.8 years (median, 37 years; range, 1–86 years) among
the European travelers. Reasons for travel were diverse in both
groups. Europeans traveled either for tourism (59.6%, np
), visits to relatives or friends (VRFs; 21.6%, ), busi-518 np 188
ness (15.8%, ), missionary work (7.5%, ), ornp 137 np 65
other reasons. Immigrants traveled to visit relatives or friends
(68.8%, ); for immigration (13.7%, ), tourismnp 544 np 108
(9.3%, ), or business (5.9%, ); or for other rea-np 73 np 47
sons. Use of malaria chemoprophylaxis was not frequent in
either group: 525 (60.4%) of the European travelers and 572
(72.4%) of the immigrants traveled without using it. Geograph-
ical regions where infection with falciparum malaria occurred
are shown in figure 2. While West Africa was, by far, the largest
contributor of patients to both groups, European patients pre-
sented relatively more frequently after travel to East Africa,
South Africa, and the Caribbean. Presenting signs and symp-
toms in all patients with falciparum malaria are shown in table
1. The majority experienced a combination of fever, headache,
and fatigue. However, other symptoms were frequently noted.
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Table 1. Signs and symptoms in European travelers and im-
migrants with falciparum malaria.
Sign or symptom
Immigrants
(n p 790)
European
travelers
(n p 869)
Fever 603 (76.3) 704 (81)
Headache 388 (49.1) 432 (49.7)
Fatigue 189 (23.9) 302 (34.8)
Myalgia, arthralgia 136 (17.2) 202 (23.2)
Diarrhea 77 (9.7) 121 (13.9)
Vomiting 96 (12.2) 104 (11.9)
Respiratory complaints 21 (2.7) 30 (3.5)
Neurological complaints 10 (1.3) 22 (2.5)
Skin affections 10 (1.3) 11 (1.3)
Otitis 56 (7.1) 8 (0.9)
Other 157 (19.9) 153 (17.6)
None 49 (6.2) 0
NOTE. Data are no. (%) of patients. Multiple entries are possible.
Treatment did not differ between European travelers and im-
migrants. A wide variety of antimalarials were used according
to national guidelines, availability, and individual patient fac-
tors. The drugs most frequently used, alone or in combination,
were quinine (65%, ), mefloquine (11.9%, ),np 1078 np 197
atovaquone/proguanil (7.6%, ), and sulfadoxine/pyri-np 126
methamine (2.5%, ). Clinical complications were re-np 41
ported in 55 European travelers (6.3%) and 29 immigrants
(3.7%). The reported complications were quite diverse and
included probable drug side effects, hyperparasitemia, and a
variety of organ manifestations, such as cerebral malaria. Five
patients died; all 5 were Europeans returning from African
countries. Thus, the mortality rate among patents reported by
TropNetEurop sites was 0.3% for all reported patients and 0.6%
for Europeans. Case-fatality rates among patients with com-
plications were 5.9% for the whole group and 9.1% for Eur-
opeans only.
DISCUSSION
Several factors appear to determine the incidence of imported
cases of malaria, including areas of endemicity visited, intensity
of exposure, and success of prophylactic measures. For conti-
nental European travelers, tropical Africa, an area where disease
endemicity is generally high and stable, is the major site of
infection with P. falciparum [1, 2, 4]. Exposure to anopheline
vectors that carry malaria parasites is affected by the duration
and type of travel and by the efficacy of antimosquito measures.
The awareness of clinicians who deal with febrile patients re-
turning from travel to malarious areas and their prescription
practices regarding chemoprophylactic drugs can both be im-
proved by regular epidemiological and clinical information.
Depending on the regional impact of immigrants and the
amount of travel in the local population, data from national
sources in Europe can be heavily skewed toward one or the
other group (figure 1). Judging from the data provided by
national systems of disease notification, TropNetEurop covers
∼10% of all patients with malaria seen in Europe [7]. It is also
the only clinical network that collects data on imported cases
of infectious diseases at a European level. As such, the network
has the capacity to provide valuable information for clinical
practice and pretravel counseling.
West Africa contributed, by far, the greatest number of ma-
laria-infected patients to TropNetEurop sites: 534 (68.2%) of
all immigrants and 511 (58.8%) of European travelers were
infected there (figure 2). Relatively more tourists were infected
in East and South Africa. However, it is difficult to contrive
risk estimates from these data. Patient numbers reported
throughout the network lack a true denominator basis because
no data are available regarding the travel activities of the pop-
ulation that contributed the patient collective. A large number
of patients returning from West Africa with falciparum malaria
may only reflect increased travel activity to that area and not
an increased risk for infection. However, reports of the World
Tourism Organization (WTO) from 1999 and 2000 show that
only 0.6%–2.4% of European travelers to potentially malarious
areas chose West Africa as their destination [8, 9]. This suggests
a comparatively high relative risk of acquiring falciparum ma-
laria in West Africa. In comparison, the WTO reports that
16%–21% of travelers from the same collective visited Southeast
Asia. Because only very few patients were reported from this
area, the relative risk appears to be very low. Obviously, the
risk of infection is highest for travelers to tropical Africa. These
findings are comparable to those of previous investigations
from various countries where malaria is not endemic [4, 10,
11]. Many immigrants enter the European continent illegally.
Because reliable data are not available for movements of this
group, areas where immigrants would be at high risk for malaria
can only be guessed. The comparatively high percentage of
patients with malaria among travelers returning from the Car-
ibbean (2.3%) reflects an outbreak of falciparum malaria on
the east coast of the Dominican Republic that was detected and
reported by TropNetEurop [12]. This area previously was ma-
laria free; control measures taken by local authorities stopped
the outbreak within 3 months.
Only a minority of patients took drugs or drug combinations
appropriate for the drug-resistance situation of malaria para-
sites at the respective destination [13]. A high percentage of
the malaria cases discussed in the present study could have
been avoided by use of an appropriate malaria prophylaxis
regimen.
Not surprisingly, the course of illness tended to be milder
in immigrants compared with Europeans (table 1), although
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available data are not sufficient to show clear differences. A
large number of patients in the former group were semi-im-
mune inhabitants of areas of endemicity, whereas European
patients were all nonimmune. Forty-nine immigrants showed
no symptoms at all and had malaria diagnosed by positive blood
smear results during routine investigations. It is notable, how-
ever, that 3.7% of immigrants developed complications during
the clinical course of their disease. Although this percentage is
clearly lower than that for European patients (6.3%), some
immigrants were critically ill when presenting at the reporting
centers. Compared with European standards [7] and with find-
ings of reports published elsewhere [10], the mortality rate of
patients was low (0.6% in European travelers). This may be
attributed to the fact that TropNetEurop is a network of spe-
cialized clinics that have ample experience in dealing with com-
plicated cases of malaria.
In conclusion, data reported by member sites of Trop-
NetEurop can contribute to our understanding of the epide-
miological and clinical characteristics of imported falciparum
malaria. It is obvious that the network cannot guarantee rep-
resentative data collection throughout Europe, because mem-
bership is self-selected. In most European countries, however,
medical services for immigrants and returning travelers are
primarily offered at specialized centers. The capacity of the
network to detect and report outbreaks within a very short
time has been demonstrated elsewhere [12]. Continuous mon-
itoring of reported data will add information on epidemiolog-
ical changes in areas of endemicity, information that is urgently
needed in a setting of increasing travel activity and migration.
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